Get started
Author

Nina Sghibneva-Bobeico

Observed names: N. Sghibneva-Bobeico, Sghibneva Nina, Sghibneva-Bobeico, N., Sghibneva-Bobeico, Nina
ORCID: 0000-0001-7980-5183
Observed ORCID: 0000-0001-7980-5183
OpenAlex ID: A5023380541
Clinical patterns and complete blood count parameters in the young patients with primary myelofibrosis in the prefibrotic stage
2022 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Moldovan Journal of Health Sciences · 1
PDF
ABCL-261: Repercussions of COVID-19 Infection on Evolution of Non-Hodgkin Lymphomas
2025 · Vasile Musteata, Valeria Muntean, et al. · Clinical Lymphoma Myeloma & Leukemia
CML-371 Insights into the Management of Chronic Myeloproliferative Neoplasms: Repercussions of the Age and Molecular-Genetic Profiles
2024 · Vasile Musteata, Nina Sghibneva-Bobeico, et al. · Clinical Lymphoma Myeloma & Leukemia
Insights into the Management of Chronic Myeloproliferative Neoplasms: Repercussions of the Age and Molecular-Genetic Profiles
2024 · Vasile Musteata, Nina Sghibneva-Bobeico, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-380 Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
2023 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-052 Incursions Into the Epidemiological Spectrum and Treatment Strategy for Aggressive Non-Hodgkin Lymphomas
2023 · Vasile Musteata, Adrian Nitrean, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-052 Incursions Into the Epidemiological Spectrum and Treatment Strategy for Aggressive Non-Hodgkin Lymphomas
2023 · Vasile Musteata, Adrian Nitrean, et al. · Clinical Lymphoma Myeloma & Leukemia
MPN-380 Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
2023 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Clinical Lymphoma Myeloma & Leukemia
CLL-247 Updates of the Epidemiological Profile and Management of Chronic Lymphocytic Leukemia
2023 · Vasile Musteata, Vera Chirca, et al. · Clinical Lymphoma Myeloma & Leukemia
Epidemiological data and diagnosis pitfalls in aggressive extranodal non-Hodgkin’s lymphomas: current issues
2022 · Dumitrita Urescu, Vasile Musteata, et al. · Moldovan Journal of Health Sciences
PDF
Management of Patients with Treatment-Free Remission in Chronic Myeloid Leukemia
2022 · Vasile Musteata, Stela Pinzari, et al. · Blood
MPN-304 Analysis of Clinical and Hematological Characteristics of Primary Myelofibrosis in the Young Patients From the Republic of Moldova: A Single-Institution Experience
2022 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: MPN-304 Analysis of Clinical and Hematological Characteristics of Primary Myelofibrosis in the Young Patients From the Republic of Moldova: A Single-Institution Experience
2022 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Clinical Lymphoma Myeloma & Leukemia
Insights Into Diagnosis and Management of Advanced Multiple Myeloma
2021 · Vasile Musteata, Doina Ranga, et al. · Hematology Transfusion and Cell Therapy
Polycythemia vera: updates in diagnosis and treatment outcomes
2020 · L. Musteata, S. Pinzari, et al. · Hematology Transfusion and Cell Therapy
PDF
MPN-214: Chronic Myeloproliferative Neoplasms in Elderlies: Challenging Issues of Diagnosis and Treatment
2020 · Vasile Musteata, Valentina Stratan, et al. · Clinical Lymphoma Myeloma & Leukemia
Treating Acute Myeloid Leukemia in Elderly Patients in a Resource Limited Setting: Real World Data from a Moldovan Hematological Centre
2019 · Victor Tomacinschii, Maria Robu, et al. · Clinical Lymphoma Myeloma & Leukemia
Clinical Aspects of Idiopathic Myelofibrosis in Young Patients in the Republic of Moldova
2019 · Nina Sghibneva-Bobeico, Victor Tomacinschii · Clinical Lymphoma Myeloma & Leukemia
Policitemia vera: manifestările clinice şi rezultatele imediate şi la distanţă ale tratamentului
2018 · Larisa Musteaţă, Corcimaru Ion, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 27
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type